Virpax Pharmaceuticals logo

Virpax Pharmaceuticals Share Price Today

(NASDAQ: VRPX)

Virpax Pharmaceuticals share price is $0.19 & ₹16.53 as on 6 Mar 2025, 2.30 'hrs' IST

$0.19

Market is closed - opens 8 PM, 06 Mar 2025

View live Virpax Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Virpax Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Virpax Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Virpax Pharmaceuticals share price movements

  • Today's Low: $0.19
    Today's High: $0.20

    Day's Volatility :4.1%

  • 52 Weeks Low: $0.19
    52 Weeks High: $5.48

    52 Weeks Volatility :96.57%

Virpax Pharmaceuticals (VRPX) Returns

PeriodVirpax Pharmaceuticals IncIndex (Russel 2000)
3 Months
-51.41%
0.0%
6 Months
-76.54%
0.0%
1 Year
-95.23%
0.0%
3 Years
-99.01%
-11.6%

Virpax Pharmaceuticals (VRPX) Key Statistics

in dollars & INR

Previous Close
$0.19
Open
$0.187
Today's High
$0.195
Today's Low
$0.187
Market Capitalization
$3.0M
Today's Volume
$237.7K
52 Week High
$5.48
52 Week Low
$0.187
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-13.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-362.29%

How to invest in Virpax Pharmaceuticals Stock (VRPX) from India?

It is very easy for Indian residents to invest directly in Virpax Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Virpax Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Virpax Pharmaceuticals or VRPX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Virpax Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Virpax Pharmaceuticals shares which would translate to 4.580 fractional shares of Virpax Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Virpax Pharmaceuticals, in just a few clicks!

Returns in Virpax Pharmaceuticals (VRPX) for Indian investors in Rupees

The Virpax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Virpax Pharmaceuticals investment value today

Current value as on today

₹9,790

Returns

₹90,210

(-90.21%)

Returns from Virpax Pharmaceuticals Stock

₹95,226 (-95.23%)

Dollar Returns

₹5,016 (+5.02%)

Indian investors sentiment towards Virpax Pharmaceuticals (VRPX)

522.22%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Virpax Pharmaceuticals Shares from India has grown by 522.22% over the past 30 days, indicating increased transactional activity.

127%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Virpax Pharmaceuticals Stock from India on INDmoney has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Virpax Pharmaceuticals

  • Garden State Investment Advisory Services LLC

    0.31%

  • Geode Capital Management, LLC

    0.23%

  • HRT FINANCIAL LLC

    0.14%

  • Virtu Financial LLC

    0.13%

  • UBS Group AG

    0.07%

  • XTX Topco Ltd

    0.07%

Analyst Recommendation on Virpax Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Virpax Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Virpax Pharmaceuticals Stock (VRPX)

What analysts predicted

Upside of 1478.95%

Target:

$3.00

Current:

$0.19

Insights on Virpax Pharmaceuticals Stock (Ticker Symbol: VRPX)

  • Price Movement

    In the last 7 days, VRPX stock has moved down by -20.7%
  • VRPX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 157.9%
  • VRPX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.8%

Virpax Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Virpax Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Virpax Pharmaceuticals (VRPX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Virpax Pharmaceuticals Inc logo
-34.71%
-76.54%
-95.23%
-99.01%
-99.71%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Virpax Pharmaceuticals Inc logo
NA
NA
NA
-3.3
-3.62
-0.91
NA
-0.98
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Virpax Pharmaceuticals Inc logo
Buy
$3.0M
-99.71%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Virpax Pharmaceuticals

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Organization
Virpax Pharmaceuticals
Employees
7
CEO
Dr. Sheila A. Mathias J.D., M.B.A., Ph.D.
Industry
Miscellaneous

Management People of Virpax Pharmaceuticals

NameTitle
Dr. Sheila A. Mathias J.D., M.B.A., Ph.D.
Chief Scientific Officer

Important FAQs about investing in VRPX Stock from India :

What is Virpax Pharmaceuticals share price today?

Virpax Pharmaceuticals share price today stands at $0.19, Open: $0.19 ; Previous Close: $0.19 ; High: $0.20 ; Low: $0.19 ; 52 Week High: $5.48 ; 52 Week Low: $0.19.

The stock opens at $0.19, after a previous close of $0.19. The stock reached a daily high of $0.20 and a low of $0.19, with a 52-week high of $5.48 and a 52-week low of $0.19.

Can Indians buy Virpax Pharmaceuticals shares?

Yes, Indians can invest in the Virpax Pharmaceuticals (VRPX) from India.

With INDmoney, you can buy Virpax Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Virpax Pharmaceuticals at zero transaction cost.

How can I buy Virpax Pharmaceuticals shares from India?

It is very easy to buy Virpax Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Virpax Pharmaceuticals (VRPX) be purchased?

Yes, you can buy fractional shares of Virpax Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Virpax Pharmaceuticals stocks?

To start investing in Virpax Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Virpax Pharmaceuticals Stock (VRPX)?

Today’s highest price of Virpax Pharmaceuticals (VRPX) is $0.20.

Today’s lowest price of Virpax Pharmaceuticals (VRPX) is $0.19.

What is today's market capitalisation of Virpax Pharmaceuticals?

Today's market capitalisation of Virpax Pharmaceuticals VRPX is 3.0M

What is the 52 Week High and Low Range of Virpax Pharmaceuticals Stock (VRPX)?

  • 52 Week High

    $5.48

  • 52 Week Low

    $0.19

What are the historical returns of Virpax Pharmaceuticals (VRPX)?

  • 1 Month Returns

    -34.71%

  • 3 Months Returns

    -76.54%

  • 1 Year Returns

    -95.23%

  • 5 Years Returns

    -99.71%

Who is the Chief Executive Officer (CEO) of Virpax Pharmaceuticals ?

Dr. Sheila A. Mathias J.D., M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Virpax Pharmaceuticals.